http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2015000744-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e673458c8c443e6fcd34bbc9565bf7f7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08
filingDate 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d3925ad2809f35ac9c832eb2fe1fdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb5c5cdaca4ad279ef0b533f9e76856c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f17ab4d1b6dfca8008e03fb2d40d686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed30b98031ec25430efec436d541f335
publicationDate 2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2015000744-A
titleOfInvention PROCESS FOR THE MANUFACTURE OF ISAVUCONAZOL OR RAVUCONAZOL.
abstract The invention relates to a process for the manufacture of the triazole compounds isavuconazole and diastereomeric and enantiomerically enriched ravuconazole, comprising a Reformatsky reaction between a ketone and a 2-halozincpropionate ester, followed by a resolution step, preferably an enzymatic resolution with an enzyme esterase.
priorityDate 2012-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID467825

Total number of triples: 19.